1D·

HIMS & NOVO TEAM UP ON OBESITY CARE

$HIMS (-4,37 %) & Hers and $NOVO B (+2,49 %) have launched a long-term collaboration, starting with a bundled offering of FDA-approved Wegovy through the Hims & Hers platform. The deal aims to expand access to obesity treatment by combining innovative medication with a direct-to-consumer care platform.

22 Comentarios

Dividendenopi👴@Dividendenopi

Ohoh, @Seebi won't like that at all 😇😂😉

•

Konstantin@Konstantin85

@Dividendenopi hopefully. Maybe correct it by 1%, then he'll make 10 pointless posts again. The profile photo alone is simply gaga. Probably sunk money himself and just hated all the time.

•

Sebi@Seebi

@Konstantin85 Why so unfriendly right away. What do you have against my profile toto😃. No no pointless 10 posts! No never been invested in this chip shop, too much hype for nothing. I don't hate, this is constructive criticism. You just can't handle it, how much are you in the red.

••

Sebi@Seebi

@Dividendenopi I even expected this until May 7. But it's always the same, until then the share is pushed up and from 7 onwards profits are taken, you'll see😃

•

Dividendenopi👴@Dividendenopi

@Seebi Let's see, then we'll sengʻ. With an EK of 40, I'm going full risk and doubling my position.

•

Sebi@Seebi

@Dividendenopi yes, everyone has to know for themselves, there are so many shares on special offer at the moment, e.g. the glorious seven, that I'm sure it will soon break out to the upside. But if you want to hope and believe, and talk yourself into long-term nonsense, then you're in good hands with Novo. I'm making money at this time😀. If I were you, I would hold on and hope that you get back to plus minus zero at some point and then sell and remove the stock from the list

••

Dividendenopi👴@Dividendenopi

@Seebi On the other hand, I don't trust the Mag7. 🤷‍♂️. I don't like Tech any more than you do Novo. We still have time and will see where the journey takes us. If the dollar continues to slide like Novo, then you too can hope that the tide will lift the boat. In any case, the next few months will remain exciting

•

Konstantin@Konstantin85

@Seebi Hype about nothing? All the GLP1 hype has been priced out in the meantime. I took profits at the end of 2023 and am currently back in at 63 euros, so I'm slightly down. But that doesn't really interest me, as the price doesn't always reflect the value of the company. But calling a company like this a "chip shop" clearly shows that you are incapable of any fundamental valuation or that you throw in the towel even when it is only a few % down.

•

Sebi@Seebi

@Konstantin85 That's your problem, you're so convinced of the company's data that you're ignoring the fact that the market has absolutely no interest in it. No matter how good they are, if the share doesn't reflect that, it's a chip shop for me, yes. You, with your fundamental valuations, will see where this will lead on 7

••

Konstantin@Konstantin85

@Seebi and so one thing is certain: you have absolutely no idea and are assuming a consistently efficient market, are probably chasing ATH shares and have absolutely no patience. Hence the constant hate postings about the company. The company has already had some massive setbacks in the past. Most people here think you're a 🤡 anyway and your posts are just trolling, pure provocation 😅 "the share price doesn't reflect it so the company is a chip shop" 😅😅😅😅

•

Konstantin@Konstantin85

@Seebi ps: just like you, Amazon and Meta also hated 2023. Exactly such blunt posts 😆 what was there? Also French fries stalls for sure 🤡🤡🤡

•

Ver todas las 5 respuestas adicionales

WhenLambo@SoonLambo

Clever move by Novo, enemy becomes friend which will have a positive impact on sales and market share in my opinion.

In my opinion, Hims has shown great luck or negotiating skills, so that they can sit down at the table with the big players. Otherwise rip. 😆

•

ETF-DIY@ETF-DIY

@SoonLambo
Not stupid for Novo either

••

WhenLambo@SoonLambo

@ETF-DIY I mentioned in the first paragraph 👍

•

Bubu@Bubu_98

The + 3% at Novo simply shifts more MCap than at Hims +26 🤣

•

Ric@Ric_Sab

+36% for Novo would also have been great 😄

•

Nova@Nova_portfolio

Profits at $HIMS being taken off the table right away while $NOVO B holds ground at a (somewhat boring) +3% so clearly illustrates the different types of investors involved here

•